Follicular lymphoma (FL) is characterized by a relatively indolent clinical course, but the disease often transforms into a more aggressive large cell lymphoma with a rapidly progressive clinical course. In the present study, we analyzed 41 cases of FL known to have subsequently transformed to aggressive lymphoma and an additional 64 FL samples from patients not subsequently transformed. We studied BCL6 gene rearrangement by the methodology of long-distance inverse polymerase chain reaction (LDI-PCR). Of the 41 cases known to transform, 16 (39.0%) harbored BCL6 translocation or deletion at the time of FL diagnosis. Among 64 cases not known to transform, BCL6 translocation was detected in 9 (14.1%). The prevalence of BCL6 translocation in the group known to transform was significantly higher (P =.0048). Among the transformation cases, the partners of the BCL6 translocation were identified in 13 cases and included IGH, CIITA, U50HG, MBNL, GRHPR, LRMP, EIF4A2, RhoH/TTF, and LOC92656 (similar to NAPA), whereas in the control group the BCL6 partners were IGH, CIITA, SIAT1, and MBNL. In 13 cases paired specimens before and after transformation were available. Among these paired specimens, a loss (3 cases) or a gain (1 case) of BCL6 translocation was observed after the transformation. Analysis of clonality showed that all of these cases represented the evolution of a subclone of the original tumor population. Our study demonstrated that BCL6 translocation is not necessary for transformation but that BCL6 translocation in FL may constitute a subgroup with a higher risk to transform into aggressive lymphoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2002-08-2482 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary Gastric Atypical Burkitt Lymphoma: A Rare Case Report.
J Investig Med High Impact Case Rep
November 2024
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, USA.
Article Synopsis
- Sporadic Burkitt lymphoma (BL) usually affects the abdomen, especially the ileocecal area, while stomach involvement is extremely rare.
- This case report highlights a unique instance of atypical Burkitt lymphoma that originated in the stomach, which has not been previously documented.
- Diagnostic tests showed positive markers like CD20 and the c-MYC gene rearrangement, but the common translocations related to Burkitt lymphoma were not present.
High Prevalence of MYD88 and CD79B Mutations in Primary Sinonasal Diffuse Large B-Cell Lymphoma : Identification of an MCD-like Subtype.
Am J Surg Pathol
February 2025
Departments of Pathology and Oncology.
Article Synopsis
- Primary sinonasal diffuse large B-cell lymphoma (PSDLBCL) is a rare and aggressive type of lymphoma, predominantly associated with genetic mutations MYD88 L265P and CD79B Y196, which indicate a poor prognosis.
- In a study involving 55 patients, researchers utilized droplet digital PCR and FISH to identify these mutations and translocations, finding high prevalence rates (52.7% for MYD88 and 36.4% for CD79B), with 58.2% of cases categorized as the aggressive MCD-like subtype.
- The MCD-like subtype showed a tendency for relapse in areas like the CNS and had worse overall and progression-free survival rates compared to the co-wild type
The high-grade B-cell lymphomas: double hit and more.
Blood
December 2024
School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Both the 2022 World Health Organization Classification of Hematolymphoid Tumors, 5th Edition and the International Consensus Classification of lymphoma have refined the way we now approach high-grade B-cell lymphoma (HGBL) with MYC and BCL2 and/or BCL6 rearrangements moving the previous generation of classification a step forward. The unifying biology of MYC/BCL2 tumors has become clearer and their inferior prognosis confirmed compared with those with morphologic similar phenotypes but lacking the classifcation defining cytogenetic abnormalities. Fluorescent in situ hybridization testing has now become largely population based, and we have learned much from this.
View Article and Find Full Text PDFCODOX-M/IVAC-R DA-EPOCH-R in double hit/triple hit lymphoma patients aged 60 years or under.
Haematologica
October 2024
Division of Hematology, Mayo Clinic, Rochester, MN.
Intensified chemoimmunotherapy regimens are often used in young patients with double hit and triple hit lymphoma (DHL/THL) despite no survival benefit compared to R-CHOP. Favorable retrospective reports on the application of CODOX-M/IVAC-R are subject to selection bias as only young fit patients can tolerate this treatment. We conducted a retrospective analysis to investigate outcome differences between CODOX-M/IVAC-R and DA-EPOCH-R in DHL/THL patients aged 60 years or younger.
View Article and Find Full Text PDFMYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.
Blood Cancer J
October 2024
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Aggressive B-cell non-Hodgkin lymphomas (NHL) in children, adolescents, and young adults (CAYA) include Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), and a subset of high-grade tumors with features intermediate between these entities whose genetic and molecular profiles have not been completely elucidated. In this study, we have characterized 37 aggressive B-NHL in CAYA, 33 with high-grade morphology, and 4 DLBCL with MYC rearrangement (MYC-R), using targeted next-generation sequencing and the aggressive lymphoma gene expression germinal center B-cell-like (GCB), activated B-cell-like (ABC), and dark zone signatures (DZsig). Twenty-two tumors had MYC-R without BCL2 breaks, and two MYC-non-R cases had BCL6 translocations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!